The UK has a vibrant ecosystem supporting early-stage life science start-ups, with accelerators helping companies raise significantly larger seed rounds and exit more efficiently. Our report highlights a critical gap: there is an urgent need for further support to help companies grow beyond scale, particularly given current headwinds. Addressing this is essential to sustain the UK’s global competitiveness in life sciences.
A new partnership with ARC West London, designed to support innovators across AI, life sciences, robotics and digital industries to scale, bolstering the West London life sciences ecosystem.
Stablepharma are delighted to announce that they have been selected to be part of Innovate UK’s prestigious Scaleup Programme, recognising the company's potential to grow exponentially and scale globally.
PULSE – the Programme for Up-and-coming Life Science Entrepreneurs – was launched in 2018 to help new entrepreneurs understand how innovative ideas are made into reality through commercialisation, and to provide them with an instant open door to a network of important connections. Read this report to learn more about PULSE's role in shaping biotech innovation.
In this blog, Albert Maguire-King, Media and Communications Executive at the BIA, discusses the recent Techbio Boost event hosted by KQ Labs and the BIA, highlighting the programme's role in supporting the growth of London-based techbio seed and pre-series A companies.
